Čes. stomatol. Prakt. zub. lék. (Czech Dental Journal) 2009; 109(1): 7-13

Advances in Pharmacotherapy of Oral Mucosa Diseases

R. Slezák*, Z. Šustová, V. Nováková
Stomatologická klinika LF UK a FN, Hradec Králové

In this review are characterized some new drugs useful in the treatment of diseases of the oral mucosa. They are Gelclair®, imiquimod and tacrolimus for topical use only and mycophenolate mofetil, voriconazole, posaconazole and valganciclovir for systemic administration.

Keywords: oral mucosa; pharmacotherapy

Published: March 1, 2009  Show citation

ACS AIP APA ASA Harvard Chicago Chicago Notes IEEE ISO690 MLA NLM Turabian Vancouver
Slezák R, Šustová Z, Nováková V. Advances in Pharmacotherapy of Oral Mucosa Diseases. Čes. stomatol. Prakt. zub. lék. 2009;109(1):7-13.
Share...
Download citation
  • BibTeX (.bib)
  • Bookends (.ris)
  • EasyBib (.ris)
  • EndNote (.enw)
  • EndNote 8 (.xml)
  • ISI WoS (.isi)
  • Medlars (.medlars)
  • Mendeley (.ris)
  • MODS (.xml)
  • Papers (.ris)
  • RefWorks (.txt)
  • RefManager (.ris)
  • RIS (.ris)
  • MS Word (.xml)
  • Zotero (.ris)
    • Open full article

    References

    1. Bagg, J., Sweeney, M. P., Davies, A. N., Jackson, M. S., Brailsford, S.: Voriconazole susceptibility of yeasts isolated from the mouths of patients with advanced cancer. J. Med. Microbiol., roč. 54, 2005, s. 959-964. Go to original source... Go to PubMed...
    2. Baker, R.: Posaconazole versus fluconazole for the treatment of oropharyngeal candidiasis in HIV patients. In: http://www.hivandhepatitis.com.
    3. Burn, K., Fothergill, A. W., Kirkpatrick, W. R., Coco, B. J., Patterson, T. F., McCarthy, D. I., Rinaldi, M. G., Redding, S. W.: Comparison of antifungal susceptibilities to fluconazole and voriconazole of oral Candida glabrata isolates from head and neck radiation patients. J. Clin. Microbiol., roč. 42, 2004, č. 12, s. 5846-5848. Go to original source... Go to PubMed...
    4. Hodgson, T. A., Sahni, N., Kaliakatsou, F., Buchanan, J. A. G., Porter, S. R.: Long-term efficacy and safety of topical tacrolimus in the management of ulcerativeerosive oral lichen planus. Eur J. Dermatos., roč. 13, 2003, č. 5, s. 466-470.
    5. http://www.gelclair.co.uk
    6. Kovandová, H.: Imiquimod v terapii kožních onemocnění. Derm. Praxi, roč. 1, 2007, č. 4, s. 188-190.
    7. Krejsek, J., Kopecký, O.: Modulace imunitního systému (kap.). In: Krejsek. J., Kopecký, O.: Klinická imunologie, Hradec Králové. Nucleus HK, 2004, s. 804-810.
    8. Lener, E. V., Brieva, J., Schachter, M., West, L. E., West, D. P.: Successful treatment of erosive lichen planus with topical tacrolimus. Arch. Dermatos., roč. 137, 2001, č. 4, s. 419-422.
    9. Ojha, J., Islam, N.; Cohen, D. M., Marsal, D., Reavis, M. R., Bhattacharyya, I.: Post-transplant lymphoproliferative disorders of oral cavity. Oral Surg. Oral Med. Oral Pathol. Oral Radiol. Endod., roč. 105, 2008, č. 5, s. 589-596. Go to original source... Go to PubMed...
    10. Smith, K. J., Germain, M., Yeager, J., Skeleton, H.: Topical 5% imiquimod for the therapy of actinic cheilitis. J. Amer. Acad. Dermatol, roč. 47, 2002, 4, s. 497-501. Go to original source... Go to PubMed...
    11. Thoma-Uszynski, S., Eming, R.: Novel therapeutic approaches in autoimmune skin disorders (kap.). In: Hertl, M. (Ed): Autoimmune diseases of the skin. Pathogenesis, diagnosis, management. Springer, Wien New York, 2. vyd., 2005, s. 421-456. Go to original source...
    12. Vazquez, J. A., Siest, D. J., Nieto, L., Northland, R., Sanne, I., Gogate, J., Greaves, W., Isaacs, R.: A multicenter randomized trial evaluating posaconazole versus fluconazole for the treatment of oropharyngeal candidiasis in subjects with HIV/AIDS. Clin. Infect Dis, roč. 42, 2006, s. 1179-1186. Go to original source... Go to PubMed...
    13. Vokurka, S.: Mukositida dutiny ústní u pacientů po chemoterapii. Kompendium ambulantní medicíny. Medical Tribune, roč. 7, 2008, č. 10/3 2008, s. 8.
    14. Weberová, J., Vobořil, R., Semecký, V.: Mycophenolat mofetil, nové perspektivní imunosupresivum. Čes. slov. Farm., roč. 51, 2002, č. 5: s. 220-225.

    This is an open access article distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License (CC BY-NC 4.0), which permits non-comercial use, distribution, and reproduction in any medium, provided the original publication is properly cited. No use, distribution or reproduction is permitted which does not comply with these terms.


    Return to the content